AOLS (Aeolus Pharmaceuticals) Pretax Margin %: -7,300.00% (As of Jun. 2017)


What is Aeolus Pharmaceuticals Pretax Margin %?

Aeolus Pharmaceuticals AOLS Pretax Margin % is -7,300.00% as of Jun. 2017.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Aeolus Pharmaceuticals's Pre-Tax Income for the three months ended in Jun. 2017 was $-0.95 Mil. Aeolus Pharmaceuticals's Revenue for the three months ended in Jun. 2017 was $0.01 Mil. Therefore, Aeolus Pharmaceuticals's pretax margin for the quarter that ended in Jun. 2017 was -7,300.00%.

The historical rank and industry rank for Aeolus Pharmaceuticals's Pretax Margin % or its related term are showing as below:


AOLS's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.295
* Ranked among companies with meaningful Pretax Margin % only.

Aeolus Pharmaceuticals  (OTCPK:AOLS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Aeolus Pharmaceuticals Pretax Margin % Related Terms

Aeolus Pharmaceuticals Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Aeolus Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aeolus Pharmaceuticals Pretax Margin % Chart

Aeolus Pharmaceuticals Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.28 -81.67 -0.83 -84.47 -171.39

Aeolus Pharmaceuticals Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -132.12 -187.36 -1,309.64 -802.33 -7,300.00

AOLS vs RDGL, PCYN, YBAO: Pretax Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aeolus Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aeolus Pharmaceuticals Pretax Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aeolus Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Aeolus Pharmaceuticals's Pretax Margin % falls into.


Aeolus Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Aeolus Pharmaceuticals's Pretax Margin for the fiscal year that ended in Sep. 2016 is calculated as

Pretax Margin=Pre-Tax Income (A: Sep. 2016 )/Revenue (A: Sep. 2016 )
=-3.558/2.076
=-171.39 %

Aeolus Pharmaceuticals's Pretax Margin for the quarter that ended in Jun. 2017 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2017 )/Revenue (Q: Jun. 2017 )
=-0.949/0.013
=-7,300.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -7,300.00% mean?
Aeolus Pharmaceuticals (AOLS) has a Pretax Margin % of -7,300.00% as of Jun. 2017. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Aeolus Pharmaceuticals and its competitors.
Is Aeolus Pharmaceuticals' Pretax Margin % too high?
Aeolus Pharmaceuticals' current Pretax Margin % is -7,300.00%.
How does Aeolus Pharmaceuticals' Pretax Margin % compare to RDGL and PCYN?
Aeolus Pharmaceuticals' Pretax Margin % of -7,300.00% can be compared against companies in the Drug Manufacturers industry. The industry median Pretax Margin % is 7.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Aeolus Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aeolus Pharmaceuticals's current Pretax Margin % is -7,300.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aeolus Pharmaceuticals stock overvalued right now?
Aeolus Pharmaceuticals (AOLS) has a current Pretax Margin % of -7,300.00%. The current Pretax Margin % is -7,300.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Aeolus Pharmaceuticals (AOLS), the current Pretax Margin % is -7,300.00% as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aeolus Pharmaceuticals Business Description

Address 26361 Crown Valley Parkway, Suite 150, Mission Viejo, CA, USA, 92691
Aeolus Pharmaceuticals Inc is a Southern California-based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.